N
AVNR

Nuveen’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Nuveen’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-14,950
Closed -$253K – 1697
2014
Q4 		$253K Buy
14,950
+1,163
+8% +$16.4K ﹤0.01% 1501
2014
Q3 		$164K Buy
13,787
+510
+4% +$3.48K ﹤0.01% 1513
2014
Q2 		$75K Buy
13,277
+1,184
+10% +$5.46K ﹤0.01% 1561
2014
Q1 		$44K Hold
12,093
– – ﹤0.01% 1568
2013
Q4 		$41K Buy
12,093
+875
+8% +$3.61K ﹤0.01% 1551
2013
Q3 		$47K Buy
11,218
+1,168
+12% +$5.54K ﹤0.01% 1451
2013
Q2 		$46K Buy
+10,050
New +$34.5K ﹤0.01% 1509

Nuveen's AVNR Position: Q1 2015 in Review

Nuveen sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 14,950 shares — an estimated $253K sold.

Nuveen first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $253K in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Nuveen reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Nuveen sold 14,950 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $253K.
  • Nuveen first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
  • Nuveen's AVANIR PHARMACEUTICALS, INC CL A position peaked at $253K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Nuveen's 13F filing for Q1 2015, filed 15 May 2015.